Clinical Trial Update: Post-Authorization Study Evaluating Safety Of Tigecycline

View source ↗

Summary

Pfizer completed a post-authorization safety study evaluating tigecycline, with results posted in February 2012. The safety data cover patients treated for intr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infections
• Skin and Soft Tissue Infections

Drugs mentioned

• Tigecycline (Tygacil) (tigecycline)

Snippet

Sponsor: Pfizer | Conditions: Intra-Abdominal Infections, Skin Disease, Infectious | Status: COMPLETED | Results posted: 2012-02-01